The functional evidence of the involvement of Notch2 in preserving survival of trisomy 12 CLL cells is given by the genetic silencing or pharmaceutical inhibition of its expression by gliotoxin that demonstrates an impairment of Mcl-1 expression and consequently a reduction of leukemic cell viability. Here, NOTCH2 is linked to B-cell chronic lymphocytic leukemia.